{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:30:20Z","timestamp":1786199420360,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nmd.2020.04.007","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T12:10:23Z","timestamp":1589544623000},"page":"611-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome"],"prefix":"10.1016","volume":"30","author":[{"given":"Mohammad A.","family":"Al-Muhaizea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"AlQuait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan","family":"AlRasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoug","family":"AlHarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoud Abdulmalik","family":"Albader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"AlMass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albandary","family":"Albakheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alhumaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"AlRasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namik","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.04.007_bib0001","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpn.2011.03.006","article-title":"Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes","volume":"15","author":"Barisic","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0002","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.nmd.2014.09.002","article-title":"Congenital myasthenic syndrome in Japan: ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits","volume":"25","author":"Azuma","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.nmd.2013.03.003","article-title":"Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1","volume":"23","author":"Basiri","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nmd.2017.11.013","article-title":"Congenital myasthenic syndromes in Turkey: clinical clues and prognosis with long term follow-up","volume":"28","author":"Durmus","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0006","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.nmd.2018.08.007","article-title":"Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil","volume":"28","author":"Estephan","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0007","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nmd.2013.06.002","article-title":"DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children","volume":"23","author":"Klein","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0008","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.nmd.2014.11.013","article-title":"Congenital myasthenic syndrome caused by mutations in DPAGT","volume":"25","author":"Klein","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nmd.2015.10.013","article-title":"Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations","volume":"26","author":"Natera-de Benito","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.nmd.2016.08.005","article-title":"Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation. A long-term follow-up","volume":"26","author":"Natera-de Benito","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0011","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.nmd.2015.08.001","article-title":"Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis","volume":"25","author":"Santos","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0012","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nmd.2011.09.002","article-title":"Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations","volume":"22","author":"Wargon","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0013","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2020.04.007_bib0014","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1469-8749.2007.00629.x","article-title":"Childhood myasthenia: clinical subtypes and practical management","volume":"49","author":"Parr","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nmd.2016.11.014","article-title":"Congenital myasthenic syndrome in Israel: genetic and clinical characterization","volume":"27","author":"Aharoni","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0016","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nmd.2018.06.020","article-title":"A new severe mutation in the SLC5A7 gene related to congenital myasthenic syndrome type 20","volume":"28","author":"Pardal-Fernandez","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.04.007_bib0017","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/acn3.387","article-title":"Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome","volume":"4","author":"Shen","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bay119","article-title":"Ensembl variation resources","volume":"2018","author":"Hunt","year":"2018","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.nmd.2020.04.007_bib0019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/jmedgenet-2014-102592","article-title":"ISCA2 mutation causes infantile neurodegenerative mitochondrial disorder","volume":"52","author":"Al-Hassnan","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2020.04.007_bib0020","article-title":"Genetic and phenotypic characterization of NKX6-2-related spastic ataxia and hypomyelination","author":"Chelban","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0021","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/jmedgenet-2015-103637","article-title":"KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability","volume":"53","author":"Kaya","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2020.04.007_bib0022","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.24905","article-title":"Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome","volume":"81","author":"Salpietro","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/ETLS20180100","article-title":"Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome","volume":"3","author":"Thompson","year":"2019","journal-title":"Emerg Top Life Sci"},{"key":"10.1016\/j.nmd.2020.04.007_bib0024","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-020-02128-8","article-title":"Truncating mutations in YIF1B cause a progressive encephalopathy with various degrees of mixed movement disorder, microcephaly, and epilepsy","author":"AlMuhaizea","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00401-019-02109-6","article-title":"Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases","volume":"139","author":"Perenthaler","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2020.04.007_bib0026","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2013.08.001","article-title":"Mutations in NALCN cause an autosomal-recessive syndrome with severe hypotonia, speech impairment, and cognitive delay","volume":"93","author":"Al-Sayed","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2020.04.007_bib0027","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12311-017-0893-2","article-title":"A novel homozygous mutation in sptbn2 leads to spinocerebellar ataxia in a consanguineous family: report of a new infantile-onset case and brief review of the literature","volume":"17","author":"Al-Muhaizea","year":"2018","journal-title":"Cerebellum"},{"key":"10.1016\/j.nmd.2020.04.007_bib0028","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mgg3.480","article-title":"Contribution of next generation sequencing in pediatric practice in Lebanon. A study on 213 cases","volume":"6","author":"Nair","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.nmd.2020.04.007_bib0029","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00439-017-1821-8","article-title":"The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes","volume":"136","author":"Monies","year":"2017","journal-title":"Hum Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:37Z","timestamp":1760774977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620300997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0960896620300997"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.04.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}